Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

Public concern on mental health has noticeably increased given the high prevalence of neuropsychiatric disorders. Cognition and emotionality are the most affected functions in neuropsychiatric disorders, i.e. anxiety disorders, depression and schizophrenia. In this review, most relevant literature o...

Full description

Bibliographic Details
Main Authors:	Eva M Marco, María S. eGarcía-Gutiérrez, Francisco-Javier eBermúdez-Silva, Fabricio eMoreira, Francisco eGuimarães, Jorge eManzanares, Maria-Paz eViveros
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2011-10-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	Anxiety Cannabidiol Cognition Depression Eating Disorders Schizophrenia
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnbeh.2011.00063/full

Similar Items

The endocannabinoid system and stroke: A focused review
by: Bradley Kolb, et al.
Published: (2019-01-01)

Post-learning molecular reactivation underlies taste memory consolidation
by: Kioko eGuzman-Ramos, et al.
Published: (2011-09-01)

The role of cannabinoids and endocannabinoid system in the treatment of epilepsy
by: Pędracka Monika, et al.
Published: (2015-12-01)

Antibodies against invasive phenotype-specific antigens increase Mycobacterium avium subspecies paratuberculosis translocation across a polarized epithelial cell model and enhance killing by bovine macrophages
by: Jamie eEverman, et al.
Published: (2015-08-01)

Role and Function of Endocannabinoid System in Major Depressive Disease
by: Erhan Yarar
Published: (2020-12-01)

From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia
by: Kurt Leroy Hoffman
Published: (2021-07-01)

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
by: Ani Gasparyan, et al.
Published: (2021-06-01)

Advances in Neurobiology and Pharmacology of GPR12
by: Gonzalo Allende, et al.
Published: (2020-05-01)

Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice
by: Eva M. Schleicher, et al.
Published: (2019-05-01)

Endocannabinoid system involvement in autism spectrum disorder: An overview with potential therapeutic applications
by: Stephen Schultz, et al.
Published: (2019-05-01)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
by: Francisco Navarrete, et al.
Published: (2020-04-01)

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
by: Yann Chye, et al.
Published: (2019-02-01)

Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
by: Luca Steardo, et al.
Published: (2021-03-01)

Uso terapêutico dos canabinoides em psiquiatria Therapeutical use of the cannabinoids in psychiatry
by: José Alexandre S. Crippa, et al.
Published: (2010-05-01)

Dreaming and the neurobiology of self: recent advances and implications for psychiatry
by: Armando eD’Agostino, et al.
Published: (2013-09-01)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021-05-01)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
by: María S. García-Gutiérrez, et al.
Published: (2020-11-01)

The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction
by: Francisco-Javier Bermúdez-Silva, et al.
Published: (2011-08-01)

Focus on PTEN regulation
by: Miriam eBermudez-Brito, et al.
Published: (2015-07-01)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
by: Ana Pilar Pérez-Acevedo, et al.
Published: (2020-12-01)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
by: Francesco Paolo Busardò, et al.
Published: (2021-01-01)

Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages
by: Luiz eBermudez, et al.
Published: (2015-08-01)

Species of Staphylococcus and Bacillus isolated from traditional sausages as producers of biogenic amines.
by: Roberto eBermúdez, et al.
Published: (2012-04-01)

The Pharmacological Effects of Plant-Derived versus Synthetic Cannabidiol in Human Cell Lines
by: Ryan F. Maguire, et al.
Published: (2021-07-01)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
by: Nilson C. Ferreira-Junior, et al.

Inhibition of the Plasma-Membrane Associated Serine Protease Cathepsin G by Mycobacterium tuberculosis Rv3364c Suppresses Caspase-1 and Pyroptosis in Macrophages
by: Lia eDanelishvili, et al.
Published: (2012-01-01)

Perspectives in veterinary medicine on the use of cannabinoids as complementary palliative therapy for pain in cancer patients
by: Cláudia Sampaio Fonseca Repetti, et al.
Published: (2019-02-01)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01)

PRECLINICAL DEVELOPMENT OF PHYTOCANNABINOID- AND ENDOCANNABINOID- BASED PHARMACOTHERAPIES FOR THE TREATMENT OF ETHANOL-INDUCED NEURODEGENERATION
by: Liput, Daniel J
Published: (2013)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
by: Antonio W. Zuardi, et al.
Published: (2017-05-01)

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
by: Paula Morales, et al.
Published: (2017-06-01)

Alteration of the Canine Metabolome After a 3-Week Supplementation of Cannabidiol (CBD) Containing Treats: An Exploratory Study of Healthy Animals
by: Elizabeth M. Morris, et al.
Published: (2021-07-01)

Feeding Cannabidiol (CBD)-Containing Treats Did Not Affect Canine Daily Voluntary Activity
by: Elizabeth M. Morris, et al.
Published: (2021-04-01)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
by: Ila M. P. Linares, et al.
Published: (2018-04-01)

Cannabinoid CB1 receptor agonists do not decrease, but may increase, acoustic trauma-induced tinnitus in rats
by: Yiwen eZheng, et al.
Published: (2015-03-01)

CONSIDERATIONS ON THE CANNABIDIOL IN THE PSYCHOTHERAPY PROCESS OF CHILDREN WITH AUTISTIC SPECTRUM DISORDER
by: Allana Daiara Correia Oliveira, et al.
Published: (2019-12-01)

Epilepsy and cannabidiol - a new perspective for seizures treatment
by: Ilona Kozioł, et al.
Published: (2021-08-01)

Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes
by: Hollis C. Karoly, et al.
Published: (2020-12-01)

Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients
by: Fanelli G, et al.
Published: (2017-05-01)

ESTUDIO DEL CONTENIDO DE CANABINOIDES EN MUESTRAS DE MARIHUANA (Cannabis sativa L.) CULTIVADAS EN VARIAS REGIONES DE COLOMBIA STUDY OF CANNABINOIDS CONTENT IN MARIHUANA SAMPLES (Cannabis sativa L.) CULTIVATED IN SEVERAL REGIONS OF COLOMBIA
by: Néstor M FLORIAN R, et al.
Published: (2009-05-01)